BT3:FRA
Lineage Cell Therapeutics Inc
0,88 €
arrow_downward
-0,79%(-0,0070) 1K
12-okt, 22:00:00 (GMT+2) · EUR
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoBT3 tikeri uchun statistika yaratilmoqda...
Ochish
0,88 €
Yuqori
0,88 €
Past
0,88 €
Bozor kapitali
242,27Â mln
Oʻrtacha hajm
37,00
Hajmi
0,00
52 haftalik eng yuqori
1,69 €
52 haftalik eng past
0,78 €
Xodimlar soni
75
Ochish
0,88 €
Yuqori
0,88 €
Past
0,88 €
Bozor kapitali
242,27Â mln
Oʻrtacha hajm
37,00
Hajmi
0,00
52 haftalik eng yuqori
1,69 €
52 haftalik eng past
0,78 €
Xodimlar soni
75
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Benzinga
·
15 soat oldin
Transcript: Lineage Cell Therapeutics Q2 2026 Earnings Conference Call
Profil
Lineage Cell Therapeutics, Inc. is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Lineage’s programs are based on its robust proprietary cell-based therapy platform and associated in-house development and manufacturing capabilities. With this platform, Lineage develops and manufactures specialized, terminally differentiated human cells from its pluripotent and progenitor cell starting materials. These differentiated cells are developed to either replace or support cells that are dysfunctional or absent due to degenerative disease or traumatic injury or administered as a means of helping the body mount an effective immune response to cancer. Wikipedia
Lineage Cell Therapeutics Inc haqida